Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NL-OMON40737
NL-OMON40737CompletedNot Applicable

T-cell response in CIDP, a biomarker study - Biomarkers in CIDP

Academisch Medisch Centrum0 sites90 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
90
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • •- Newly diagnosed untreated patients who fulfill the clinical and electrophysiological EFNS/PNS criteria for CIDP OR
  • •- Patients diagnosed with CIDP according to the clinical and electrophysiological EFNS/PNS criteria for CIDP with maintenance IVIg treatment (> 6 months of treatment) OR
  • •- Patients diagnosed with CIDP according to the clinical and electrophysiological EFNS/PNS criteria for CIDP with a stable clinical condition without treatment in the last 12 months.
  • •- Adult males or females (18 year or more)

Exclusion Criteria

  • •Lack of informed consent of the subject.

Investigators

Similar Trials

Withdrawn
Not Applicable
Monitoring of DC and T cell functions in healthy controls and patients with prostate cancer treated with GM-CSF transduced allogeneic vaccines and anti-CTLA-4
NL-OMON34152Vrije Universiteit Medisch Centrum12
Not yet recruiting
Not Applicable
Post vaccination immunological response and immune monitoring for SARS-CoV-2
CTRI/2021/08/035338Medanta Institute of Education and Research
Completed
Early Phase 1
Characterization of T-Cell Response in Participants Previously Treated With JNJ-54861911 (Atabecestat)Alzheimer Disease
NCT03587376Janssen Research & Development, LLC9
Completed
Not Applicable
Analysis of PD-1 and T cells in the pathophysiology of autoimmune thyroid disease and diabetes mellitusautoimmune thyroid disease and diabetes
JPRN-UMIN000047092Dokkyo Medical University117
Completed
Not Applicable
Evaluation of regulatory T cell and disease activity after transdermal administration of Dovonex(r) ointment 50ug/g in patients with rheumatoid arthritisRheumatoid arthritis
JPRN-UMIN000022296Medical Co.LTA PS Clinic20